07 Jan 2001

Rytmonorm® 10 (Rytmonorm® 10 mg Dragees (f. Kdr.)) - Deutschland

Updated: 07 Jan 2001

Rytmonorm® 10 mg; -150 mg | -300 mg; Rytmonorm®

Symptomatische und behandlungsbedürftige tachykarde supraventrikuläre Herzrhythmusstörungen, wie z. B. AV-junktionale Tachykardien, supraventrikuläre Tachykardien bei WPW-Syndrom od. paroxysmales Vorhofflimmern; schwerwiegend symptomatische ventrikuläre tachykarde Herzrhythmusstörungen, wenn diese lebensbedrohend sind.

Rytmonorm® 10 Description, Presentation and Dosage

Rytmonorm® 10 Description

Rytmonorm® 10 Drug Class Description


Rytmonorm® 10 Drug Description

1 Drg. enth.: Propafenon-HCl 10 mg.

Rytmonorm® 10 Generic Name

Rytmonorm® 10 mg Dragees (f. Kdr.)

Rytmonorm® 10 Presentation

Rytmonorm® 10 Presentation

Rytmonorm® 10 mg; -150 mg/-300 mg; Rytmonorm®

Rytmonorm® 10 Manufacturer

Knoll Deutschland

Related Learning Zones

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Rytmonorm® 10 Dosage

Rytmonorm® 10 Adult Dosage

Arabisches Gummi, Calciumcarbonat, Carmellose-Natrium, Carnaubawachs, hochdisperses Siliciumdioxid, Lactose 1H2O, Magnesiumstearat, Maisstärke, mikrokristalline Cellulose, Povidon (Konstante K = 25), Povidon (Konstante K = 30), Saccharose, Talkum, Titandioxid (E 171). (E 171).

Rytmonorm® 10 Child Dosage

Rytmonorm® 150 mg/-300 mg Filmtabletten (f. Erw.)
Zus.: 1 Filmtbl. enth.: Propafenon-HCl 150 mg/300 mg.
Weit. Bestandteile: Croscarmellose-Natrium, gereinigtes Wasser, Macrogol 400, Macrogol 6000, Magnesiumstearat, Maisstärke, Hypromellose, mikrokristalline Cellulose, Titandioxid

Rytmonorm® Injektionslösung
Zus.: 20 ml enth.: Propafenon-HCl 70 mg.
Weit. Bestandteile: Glucose 1H2O für Injektionszwecke zur Herstellung der Blutisotonie 1,076  g, Wasser f. Inj.-zwecke.

Rytmonorm® 10 Precautions, Reactions and Contraindications

Rytmonorm® 10 Special Precautions

Rytmonorm® 10 Special Precautions

P 140

Rytmonorm® 10 Adverse Reactions

Rytmonorm® 10 Adverse Reactions

P 140

Related Drugs - Cardiology

Back to top